Tag: EHRA 2022

“Solid” data point to benefit of early rhythm control for AF...

Findings of the EAST-AFNET 4 trial, examining the benefit of early rhythm control therapy in patients with newly diagnosed atrial fibrillation (AF), should influence...

EHRA 2022: GPs back routine AF screening

Screening for atrial fibrillation (AF) should be integrated into flu vaccination and cancer screening programmes, according to a survey of general practitioners (GPs) conducted...

EHRA 2022: ECG reading could pinpoint COVID-19 patients at high risk

A simple electrocardiogram (ECG) can pinpoint hospitalised COVID-19 patients at high risk of death who might need intensive management, according to the authors of...

EHRA 2022: Overweight patients at greater risk of AF recurrence

Overweight patients with atrial fibrillation (AF) are more likely to experience a return of the heart rhythm disorder after a corrective procedure than those...

EHRA 2022: PROFID points to role for CMR in predicting sudden...

Use of cardiac magnetic resonance (CMR) may relevant role of CMR in risk stratification for sudden cardiac death after myocardial infarction, to late-breaking research...

EHRA 2022: New guidance seeks to prevent cardiac device interference

Recommendations on the prevention and management of interference caused by medical procedures in patients with implanted electronic cardiac devices has been published today in...

EHRA 2022: Experts preach caution on “over-the-counter” heart rhythm monitoring devices

The “exponential growth” in the use of digital devices for monitoring arrhythmias has led to the development of a new international consensus document. The...

Updated cardiac mapping system among Philips’ EHRA 2022 offering

The launch of the latest KODEX-EPD cardiac mapping and navigation system is among the features Royal Philips will showcase at the 2022 European Heart...